Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Mural Oncology plcMural Oncology Reports $3.7 Million Net Loss and Significant Organizational Changes
UroGen Pharma Ltd.UroGen Pharma Reports $27.5M Revenue in Q3 2025, Net Loss Increases to $33.3M
SOUTH PLAINS FINANCIAL, INC.South Plains Financial Reports 45.5% Increase in Net Income for Q3 2025
SILENCE THERAPEUTICS PLCSilence Therapeutics Reports Significant Revenue Decline and Increased Net Losses for Q3 2025
Backblaze, Inc.Backblaze Reports 14% Revenue Growth to $37.2 Million in Q3 2025
NOVAVAX INCNovavax Reports $70.4 Million Revenue in Q3 2025, Down 16.6% Year-Over-Year
Lantheus Holdings, Inc.Lantheus Holdings Reports Q3 2025 Revenue of $384M, Net Income Declines 78.8%
Safehold Inc.Safehold Inc. Reports Revenue Growth to $96.2 Million in Q3 2025
NEXTNAV INC.NextNav Inc. Reports Q3 2025 Revenue Decline and Increased Operating Losses
TerrAscend Corp.TerrAscend Reports Q3 2025 Financial Results with $65.1M Revenue and Net Loss Improvement
COLLEGIUM PHARMACEUTICAL, INCCollegium Pharmaceutical Reports 31.4% Revenue Growth to $209.4 Million in Latest Quarter
CRESCENT BIOPHARMA, INC.Crescent Biopharma Reports $24.6 Million Net Loss in Latest Quarter, Focuses on CR-001 Development
Cronos Group Inc.Cronos Group Reports 6% Revenue Growth to $36.3 Million in Q3 2025
Alpha Metallurgical Resources, Inc.Alpha Metallurgical Resources Reports 21.6% Revenue Decline in Q3 2025
Rapport Therapeutics, Inc.Rapport Therapeutics Reports $26.9 Million Net Loss in Q3 2025, Highlights R&D Progress
CONOCOPHILLIPSConocoPhillips Reports Strong Q3 2025 Financial Performance with $15.5 Billion in Revenues
REGENXBIO Inc.REGENXBIO Reports 23% Revenue Growth to $29.7 Million in Q3 2025
Acadian Asset Management Inc.Acadian Asset Management Reports 17.2% Revenue Growth in Q3 2025
Climb Bio, Inc.Climb Bio Reports $12.9 Million Net Loss in Q3 2025, Highlights R&D Expenses and Clinical Trials
Invivyd, Inc.Invivyd Reports 41% Revenue Growth to $13.1 Million, Net Loss Improves in Q3 2025
Commerce.com, Inc.Commerce.com Reports 2.8% Revenue Growth and Reduced Net Loss in Q3 2025
ACHIEVE LIFE SCIENCES, INC.Achieve Life Sciences Reports $40M Net Loss and Advances Cytisinicline Development
Amylyx Pharmaceuticals, Inc.Amylyx Pharmaceuticals Reports No Revenue and Improved Net Loss in Latest Quarter
Cullinan Therapeutics, Inc.Cullinan Therapeutics Reports $50.6 Million Net Loss in Q3 2025
WW INTERNATIONAL, INC.WW International Reports Q3 Fiscal 2025 Financial Results with Increased Net Loss and Revenue Decline